Myeloid Sarcoma of the Breast: A Diagnostic Dilemma With Pathologic Correlation
Journal of Breast Imaging · 28.07.2023 · 5 (4) · 459-466
DOI: 10.1093/jbi/wbad019 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Breast Imaging, online erschienen am 12.05.2023. Verfasst von Joyce Hsu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Duke University Hospital, Department of Radiology, Durham, NC, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Leukemia, Myeloid, Acute, Sarcoma, Myeloid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Myeloid sarcoma (MS) is a rare extramedullary solid tumor arising most often in patients with current or subsequent acute myeloid leukemia (AML). Patients of all ages may present with involvement of the skin, lymph nodes, intestinal tract, bone, and/or central nervous system. Isolated involvement of the breast is rare, and only a small number of cases have been described in the literature. Breast MS may present as a palpable mass on clinical evaluation. In this broad literature review from 2010 to 2022, the most common findings on mammography are either solitary or multiple masses, followed by architectural distortion and, less commonly, no discrete findings. Sonography may demonstrate hypoechoic or mixed echogenicity mass(es) with circumscribed or indistinct, not discrete margins. Myeloid sarcoma may present as an enhancing mass or nonmass enhancement on breast MRI and is typically moderately radiotracer avid on 18F-fluorodeoxyglucose-PET. At histopathology, MS is characterized by myeloid blasts in varying stages of granulocytic or neutrophilic maturation; diagnosis typically requires immunophenotyping. There is no consensus for treatment of MS, although systemic chemotherapy for AML is often used as MS is considered the tissue equivalent of AML. This article will discuss and illustrate imaging and pathology findings when the breast is involved by MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Duke University Hospital, Department of Radiology, Durham, NC, USA.
- Duke University Hospital, Department of Pathology, Durham, NC, USA.
- Duke University Hospital, Department of Breast Imaging, Durham, NC, USA.
- Allegheny Health Network, Breast Imaging Division, Pittsburgh, PA, USA.
Zitieren
APA
Hsu, J., Factor, R., Lowell, D. A., Sobolewski, R., & Ghate, S. V. (2023). Myeloid Sarcoma of the Breast: A Diagnostic Dilemma With Pathologic Correlation. Journal of Breast Imaging, 5(4), 459-466. https://doi.org/10.1093/jbi/wbad019
Vancouver
Hsu J, Factor R, Lowell DA, Sobolewski R, Ghate SV. Myeloid Sarcoma of the Breast: A Diagnostic Dilemma With Pathologic Correlation. Journal of Breast Imaging. 2023;5(4):459-466. doi:10.1093/jbi/wbad019
BibTeX
@article{Hsu2023,
author = {Hsu, Joyce and Factor, Rachel and Lowell, Dorothy A and Sobolewski, Robin and Ghate, Sujata V},
title = {Myeloid Sarcoma of the Breast: A Diagnostic Dilemma With Pathologic Correlation},
journal = {Journal of Breast Imaging},
year = {2023},
volume = {5},
number = {4},
pages = {459--466},
doi = {10.1093/jbi/wbad019}
}
EUVIMED